Pressure BioSciences, Inc.

Equities

PBIO

US74112E2081

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 10:21:41 2024-04-26 am EDT 5-day change 1st Jan Change
0.2268 USD +3.09% Intraday chart for Pressure BioSciences, Inc. -11.41% -31.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Pressure BioSciences, Inc. Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing CI
Transcript : CBH International LLC, Pressure BioSciences, Inc. - M&A Call
Pressure BioSciences, Inc. completed the acquisition of CBH International LLC. CI
Pressure BioSciences, Inc. Receives Open Order Agreement from West Coast Manufacturing Partner CI
Pressure BioSciences, Inc. entered into a definitive agreement to acquire CBH International LLC. CI
Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies CI
Pressure BioSciences, Inc. Announces the Publication of Pivotal Scientific Study in the Critical Field of Food Safety CI
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador CI
Transcript : Pressure BioSciences, Inc., Q3 2023 Earnings Call, Nov 21, 2023
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Reports Q3 Revenue $413,009 MT
Pressure BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Pressure Biosciences Announces Exclusive Distribution Agreement with Bioscreen Instruments Pvt Ltd CI
Pressure BioSciences' Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately CI
Transcript : Pressure BioSciences, Inc., Q2 2023 Earnings Call, Aug 22, 2023
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Posts Q2 Revenue $511,800 MT
Pressure BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Pressure BioSciences, Inc. - Special Call
Pressure BioSciences, Inc. Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and Partnering CI
Pressure BioSciences, Inc. Announces UltraShear Processed Nano-CBD Topical Spray Distribution Agreement with Premier CA Cannabis Partner Creme de Canna CI
Pressure BioSciences, Inc. Announces Agreement with Somalab International LLC for Development & Distribution of UltraShear-Enabled Nanoemulsified Health and Wellness Products CI
Transcript : Pressure BioSciences, Inc. - Special Call
Pressure Biosciences, Inc. Announces Results from Third Round of Consumer Focus Group Testing of THC Nanoemulsion Oral Spray CI
Pressure BioSciences, Inc. Partners with Veterans Service Team to Offer Exclusive Access for VST Members to a Unique, Custom-Made, UltraShear Nano-CBD & Other Products CI
Transcript : Pressure BioSciences, Inc., Q1 2023 Earnings Call, May 16, 2023
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Posts Q1 Revenue $740,600 MT
Chart Pressure BioSciences, Inc.
More charts
Pressure BioSciences, Inc. is engaged in providing broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. The Company's enabling platform, Pressure Cycling Technology (PCT), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. The Company's BaroFold technology platform allows it to enter the bio-pharma contract services and GMP manufacturing equipment sector. It has also developed the scalable and pressure-based UltraShear Technology platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be preserved using existing non-thermal technologies.
More about the company
  1. Stock Market
  2. Equities
  3. PBIO Stock
  4. News Pressure BioSciences, Inc.
  5. Earnings Flash (PBIO) PRESSURE BIOSCIENCES Posts Q1 Revenue $740,600